Drugs / Umbilical cord blood mononuclear cells
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT06792682 | Feb 2025 → Dec 2027 expected | — | Institute of Hematology & Blood Diseases Hospital, China | Recruiting | No outcome recorded |
| Phase 1 | NCT01942915 | Jan 2012 → Dec 2013 | cirrhosis of liver | Hebei Medical University | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT04689425 | Mar 2021 → Dec 2023 | ulcer of lower limbs | Peking University Third Hospital | Unknown | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT06729320 | Dec 2024 → Jun 2025 overdue | immune system disorder | Beijing GoBroad Hospital | Not yet recruiting | No outcome recorded |
| — | NCT04882683 | Jun 2021 → Jun 2022 | ulcerative colitis | Shandong Qilu Stem Cells Engineering Co., Ltd. | Unknown | No outcome recorded |
| — | NCT04997590 | Dec 2020 → Dec 2021 | — | Qianfoshan Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Umbilical Cord Blood Mononuclear Cells | “Umbilical cord blood mononuclear cells (MNC) may improve the wound repair ability.” NCT04689425 ↗5“Umbilical Cord Blood Mononuclear Cells” NCT06792682 ↗ |
| Known as | MNC | “Umbilical cord blood mononuclear cells (MNC) may improve the wound repair ability.” NCT04689425 ↗ |
| Modality | Cell therapy | “umbilical cord blood mononuclear cells transplantation” NCT01942915 ↗ |
| Route | Other | “Participants will be transplanted with umbilical cord blood mononuclear cells.” NCT01942915 ↗ |